metadata toggle
Clinical particulars
Target species
Dog, cat and rabbit.
Indications for use
Dog: For the topical treatment of conjunctivitis associated with Staphylococcus aureus and in particular the biotype Staphylococcus intermedius.
Cat: For the topical treatment of conjunctivitis associated with secondary staphylococcal infections.
Rabbit: For the topical treatment of conjunctivitis associated with staphylococcal infections.
The veterinary medicinal product should not be used in conjunctivitis cases associated with Pseudomonas spp.
Do not use in cases of known hypersensitivity to the active substance or any of the excipients.
Special warnings for each target species
In cats, the possibility of a primary cause of the conjunctivitis should be investigated and treated if possible.
In rabbits, conjunctivitis may be associated with dacryocystitis and/or dental disease. In such cases, appropriate additional treatment should be instituted.
Special precautions for use
Official, national and regional antimicrobial policies should be taken into account when the product is used.
Special precautions for use in animals
For external use only.
When the tube is squeezed, the veterinary medicinal product comes out as a thick (viscous) drop. The drop quickly becomes liquid on contact with tear fluid and does not affect the sight.
Care should be taken to avoid contamination of the contents during use and to avoid the nozzle coming into direct contact with the eye. Avoid fingers touching the tube nozzle.
Do not use the same tube to treat different animals.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Wash hands after applying the product.
Adverse reactions
Allergic reactions or hypersensitivity to the active substance or the excipients might occur. Discontinue use if hypersensitivity to the product develops.
Use during pregnancy and lactation
The product may be used safely in pregnant and lactating animals.
Amounts to be administered and administration route
One drop of the veterinary medicinal product should be instilled into the eye once or twice daily. Treatment should be continued for at least 24 hours after the eye has returned to normal.
If a clinical response is not evident after 5 days following the commencement of administration, the diagnosis should be re-established.
If the animal has one infected eye, it may be advisable to treat both eyes to prevent cross-infection. In such cases, it is better to treat the uninfected eye first to avoid transferring infection via the tube nozzle.
Withdrawal periods
Not for use in rabbits intended for human comsumption.